- Home
- TOVX vs DFNS Comparison
TOVX vs DFNS Comparison
Compare TOVX & DFNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TOVX | DFNS |
|---|---|---|
| Founded | 2001 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.1M | 11.1M |
| IPO Year | 2012 | 2020 |
Fundamental Metrics
Financial Performance| Metric | TOVX | DFNS |
|---|---|---|
| Price | $0.25 | $10.16 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $1.00 | N/A |
| AVG Volume (30 Days) | 496.8K | ★ 872.8K |
| Earning Date | 05-13-2026 | 04-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 89.07 | ★ 261.46 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $5,913,461.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.16 | $0.04 |
| 52 Week High | $0.86 | $91.00 |
Technical Indicators
Market Signals| Indicator | TOVX | DFNS |
|---|---|---|
| Relative Strength Index (RSI) | 55.94 | 40.95 |
| Support Level | $0.22 | $0.30 |
| Resistance Level | $0.26 | $91.00 |
| Average True Range (ATR) | 0.01 | 2.47 |
| MACD | 0.00 | -1.53 |
| Stochastic Oscillator | 63.40 | 9.83 |
Price Performance
Historical ComparisonAbout TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system. Product Candidates includes SYN-004 (ribaxamase) and SYN-020.
About DFNS T3 Defense Inc. Common Stock
T3 Defense Inc is a holding company that acquires and operates mission-critical defense businesses involved in national security programs. The company operates as a strategic platform, building a portfolio of mission-critical suppliers and technology companies. Its portfolio includes businesses involved in defense and aerospace technologies, such as AI software, unmanned aerial systems, electro-mechanical manufacturing, and motion control systems, as well as activities in technology distribution, licensing, and defense infrastructure development through joint ventures.